cilostazol has been researched along with HbS Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, H | 1 |
| Khan, F | 1 |
| Musharraf, SG | 1 |
| Lester, DA | 1 |
| Richards, AA | 1 |
| Younger-Coleman, NO | 1 |
| Pepple, DJ | 1 |
| Proença-Ferreira, R | 1 |
| Franco-Penteado, CF | 1 |
| Traina, F | 1 |
| Saad, ST | 1 |
| Costa, FF | 1 |
| Conran, N | 1 |
1 trial available for cilostazol and HbS Disease
| Article | Year |
|---|---|
Cilostazol and blood viscoelasticity in homozygous sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Blood Viscosity; Cilostazol; Dose-Response Relationship, Drug; Elastic M | 2014 |
2 other studies available for cilostazol and HbS Disease
| Article | Year |
|---|---|
Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
Topics: Anemia, Sickle Cell; Animals; beta-Globins; beta-Thalassemia; Cell Differentiation; Cell Proliferati | 2021 |
Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity.
Topics: Adult; Aged; Anemia, Sickle Cell; Blood Platelets; Cells, Cultured; Cilostazol; Collagen; Cyclic AMP | 2010 |